Vessel co-option and resistance to anti-angiogenic therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Biochemistry,Physiology
Link
http://link.springer.com/content/pdf/10.1007/s10456-019-09698-6.pdf
Reference204 articles.
1. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182–1186. https://doi.org/10.1056/NEJM197111182852108
2. Ferrara N, Hillan KJ, Gerber HP, Novotny W (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3(5):391–400. https://doi.org/10.1038/nrd1381
3. Gerber HP, Ferrara N (2005) Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. Cancer Res 65(3):671–680
4. Kerbel R, Folkman J (2002) Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2(10):727–739. https://doi.org/10.1038/nrc905
5. Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298–307. https://doi.org/10.1038/nature10144
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. VEGF signaling: Role in angiogenesis and beyond;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03
2. Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development;European Journal of Pharmacology;2024-02
3. The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy;International Journal of Molecular Sciences;2024-01-11
4. Cancer stem cells and angiogenesis;Pathology - Research and Practice;2024-01
5. Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies;Biomedicines;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3